DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹6,391 Cr | ₹5,639 Cr | ₹5,398 Cr | ₹5,079 Cr | ₹4,108 Cr |
What is the latest Total Expenditure of DIVIS LABORATORIES ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹6,391 Cr |
| Mar2024 | ₹5,639 Cr |
| Mar2023 | ₹5,398 Cr |
| Mar2022 | ₹5,079 Cr |
| Mar2021 | ₹4,108 Cr |
How is Total Expenditure of DIVIS LABORATORIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,391 Cr | 13.34 | |
| Mar2024 | ₹5,639 Cr | 4.46 | |
| Mar2023 | ₹5,398 Cr | 6.29 | |
| Mar2022 | ₹5,079 Cr | 23.62 | |
| Mar2021 | ₹4,108 Cr | - | |
Compare Total Expenditure of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹168,243.4 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
| MANKIND PHARMA | ₹89,250.5 Cr | -3.7% | 3.8% | -5.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1% |
3.3% |
14.2% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses